Barrier coated drug layered particles for enhanced performance of amorphous solid dispersion dosage form
Amorphous solid dispersions (ASDs) may entail tailor-made dosage form design to exploit
their solubility advantage. Surface phenomena dominated the performance of amorphous …
their solubility advantage. Surface phenomena dominated the performance of amorphous …
Modulation of drug crystallization and molecular interactions by additives in solid dispersions for improving drug bioavailability
Background: An increase in poorly water-soluble drugs makes the design of drug delivery
systems challenging. Methods: Currently, a number of prospective solid dispersions have …
systems challenging. Methods: Currently, a number of prospective solid dispersions have …
Characterizing and exploring the differences in dissolution and stability between crystalline solid dispersion and amorphous solid dispersion
X Wang, L Zhang, D Ma, X Tang, Y Zhang, T Yin… - Aaps …, 2020 - Springer
Solid dispersion is one of the most effective ways to improve the dissolution of insoluble
drugs. When the carrier can highly disperse the drug, it will increase the wettability of the …
drugs. When the carrier can highly disperse the drug, it will increase the wettability of the …
Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine
H Konno, T Handa, DE Alonzo, LS Taylor - European journal of …, 2008 - Elsevier
Amorphous solid dispersions are used as a strategy to improve the bioavailability of poorly
water-soluble compounds. When formulating with a polymer, it is important not only for the …
water-soluble compounds. When formulating with a polymer, it is important not only for the …
Generality of Enhancing the Dissolution Rates of Free Acid Amorphous Solid Dispersions by the Incorporation of Sodium Hydroxide
HJ Zhang, CW Chiang… - Molecular …, 2024 - ACS Publications
The incorporation of a counterion into an amorphous solid dispersion (ASD) has been
proven to be an attractive strategy to improve the drug dissolution rate. In this work, the …
proven to be an attractive strategy to improve the drug dissolution rate. In this work, the …
Effect of micro-environment modification and polymer type on the in-vitro dissolution behavior and in-vivo performance of amorphous solid dispersions
W Sun, B Pan - European Journal of Pharmaceutical Sciences, 2017 - Elsevier
This study investigates the effects of micro-environment modification and polymer type on
the in-vitro dissolution behavior and in-vivo performance of micro-environment pH modifying …
the in-vitro dissolution behavior and in-vivo performance of micro-environment pH modifying …
Polymeric solid dispersion Vs co-amorphous technology: A critical comparison
Historically, amorphous solid dispersion technology with polymeric carriers has been
employed to stabilize high-energy amorphous phases of poorly water-soluble drug …
employed to stabilize high-energy amorphous phases of poorly water-soluble drug …
Role of surfactants in improving release from higher drug loading amorphous solid dispersions
Amorphous solid dispersion formulations (ASD) are increasingly being used as a
formulation strategy to improve bioavailability of poorly soluble drugs. One of the limitations …
formulation strategy to improve bioavailability of poorly soluble drugs. One of the limitations …
Release Enhancement by Plasticizer Inclusion for Amorphous Solid Dispersions Containing High Tg Drugs
Purpose Plasticizers are commonly used in the preparation of amorphous solid dispersions
(ASDs) with the main goal of aiding processability; however, to the best of our knowledge …
(ASDs) with the main goal of aiding processability; however, to the best of our knowledge …
Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers
The objective of the current study is to mechanistically differentiate the dissolution and
supersaturation behaviors of amorphous drugs from amorphous solid dispersions (ASDs) …
supersaturation behaviors of amorphous drugs from amorphous solid dispersions (ASDs) …